AOD9604 6mg Product Description

AOD9604 6mg (Advanced Obesity Drug) is a highly sought-after synthetic peptide fragment derived from the C-terminus (amino acids 177–191) of human growth hormone (hGH). Known in clinical research as hGH Fragment 177-191 (with a modified tyrosine), this peptide is heavily studied for its potent lipolytic (fat-burning) properties.

Unlike unmodified growth hormone, the AOD 9604 peptide targets fat cells directly without triggering unwanted side effects such as insulin resistance, cellular proliferation, or negative impacts on blood sugar.

Key Research Benefits of AOD9604

• Targeted Lipolysis & Fat Loss: Stimulates the breakdown of stored lipids (lipolysis) and actively inhibits the formation of new fat cells (lipogenesis), with a specific affinity for stubborn adipose tissue.

• Preserves Insulin Sensitivity: Unlike standard growth hormone, research shows AOD9604 does not adversely affect blood glucose levels, making it a safer candidate for metabolic study.

• Joint & Cartilage Repair: Clinical models suggest a therapeutic role in promoting joint health, accelerating cartilage regeneration, and supporting recovery from osteoarthritis.

• Lean Muscle Preservation: Focuses metabolic activity purely on fat oxidation, ensuring that lean structural proteins and muscle tissue are fully preserved during research.

AOD9604 6mg Specifications

• Active Peptide: AOD9604 (Modified hGH Fragment 177-191)

• Concentration: 6mg per vial

• Format: Lyophilized powder (requires reconstitution)

• Purity: >98% (HPLC tested)